SCIO-469

Known as: SCIO 469 
 

Topic mentions per year

Topic mentions per year

2004-2018
02420042018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Evidence for a single-step mechanism in the origin of hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes… (More)
  • table 1
  • table 2
Is this relevant?
2011
2011
OBJECTIVE To evaluate the efficacy, safety, and tolerability of oral SCIO-469, a p38 MAPK inhibitor that blocks tumor necrosis… (More)
Is this relevant?
2008
2008
Myelodysplastic syndromes (MDS) are common causes of ineffective hematopoiesis and cytopenias in the elderly. Various… (More)
Is this relevant?
2006
2006
The myelodysplastic syndromes (MDSs) are collections of heterogeneous hematologic diseases characterized by refractory cytopenias… (More)
Is this relevant?
2006
2006
Inhibition of p38 kinase blocks the production of tumor-promoting factors in the multiple myeloma (MM) bone marrow… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
The multiple myeloma (MM) bone marrow (BM) microenvironment plays a critical role in supporting tumor growth and survival as well… (More)
Is this relevant?
2006
2006
Arsenic trioxide (As(2)O(3)) induces differentiation and apoptosis of leukemic cells in vitro and in vivo, but the precise… (More)
Is this relevant?
2005
2005
Myelodysplastic syndromes (MDS) are characterized by refractory cytopenias due to ineffective hematopoiesis in the marrow… (More)
Is this relevant?
Review
2004
Review
2004
SCIO-469 is a small-molecule p38 mitogen-activated protein (MAP) kinase inhibitor under development by Scios Inc as a potential… (More)
Is this relevant?
2004
2004
Although PS-341 (bortezomib) is a promising agent to improve multiple myeloma (MM) patient outcome, 65% of patients with relapsed… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?